tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vik Chopra, 40 are a HOLD (50.63%), 39 are a BUY (49.37%).
Analyst Vik Chopra, currently employed at BMO, carries an average stock price target met ratio of 67.21% that have a potential upside of 21.61% achieved within 114 days. Previously, Vik Chopra worked at WELLS FARGO.
Vik Chopra’s has documented 157 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ATEC, Alphatec Holdings at 05-Aug-2026.
Analyst best performing recommendations are on NPCE (NEUROPACE).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 2/27/2026. The price target of $13 was fulfilled within 7 days with a profit of $1.68 (11.44%) receiving and performance score of 16.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Feb-2024
$45
$18.94 (72.68%)
$50
Buy Since 06-Jan-2026
$40
$13.94 (53.49%)
$39
Buy Since 08-Nov-2023
$29
$2.94 (11.28%)
$42
Buy Since 12-Sep-2022
$32
$5.94 (22.79%)
$36
Buy Since 06-Apr-2022
$45
$22.29 (98.15%)
$64
Which stock is Vik Chopra is most bullish on?
Which stock is Vik Chopra is most reserved on?
What Year was the first public recommendation made by Vik Chopra?
